Drug Profile
A 80987
Alternative Names: ABT 80987; ABT 987Latest Information Update: 22 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer AbbVie
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections